CMS Expands Phone Demonstration Project

Published in Billing, Reimbursement, Audits and Compliance on Tuesday, October 23, 2018

CMS just announced the second level of appeals demonstration project is expanding into both jurisdictions A and B. The demonstration project is set to begin Nov. 1, 2018, for all product categories except diabetic testing supplies and any other projects involved in CMS initiative such as the Prior Authorization for PMDs. 

Ronda Buhrmester, VGM’s director of Reimbursement, has been pushing CMS to get this expanded into jurisdictions A and B for several years.

“We are thrilled to see the expansion of this demonstration project into the other jurisdictions,” said Buhrmester. “In August 2017, VGM and several members testified at a hearing with the Small Business Administration (SBA) proposing the program’s expansion to streamline the appeals process. At the federal level, SBA expressed a great deal of interest in establishing their support of the project, being involved in the process after the hearing.”

The demonstration project started back in January 2016 and consisted of two phases that only applied to jurisdictions C and D. The demonstration has been approved for five years. Until now, jurisdictions A and B have been part of the control group.

See the full announcement from CMS by clicking here.

The first phase of the project has given suppliers the opportunity to participate in a formal telephone discussion with C2C and offer verbal testimony. The DME suppliers discuss the facts of the case and provide any additional documentation that would assist in reaching a favorable determination.

The second phase of the demonstration is with reopenings. C2C will be able to look at those claims found unfavorable or partially unfavorable that are in the ALJ. They can only go back to Jan. 1, 2013—which is the C2C decision date on the letter, not the date of service. The contractor will open up only those claims that they feel can be overturned to a favorable decision. Don’t worry as you will not lose your place in line at the ALJ if they don’t see where the claim can be found favorable.

For both phases of this demonstration, selected suppliers receive a letter that invites them to a scheduled phone discussion. The discussion can be about technical issues or medical necessity, meaning if something is missing or can be obtained easily by the supplier, this can be accomplished during the discussion with the reviewer.

C2C has shared since the demonstration started with the formal telephone discussions the success of getting claims in a favorable state and decreasing the ALJ backlog. 

If you currently have claims at the ALJ, you can request the C2C to review for a possible reopening—and you can do this now. Go to www.C2Cinc.com where you will find the form to complete. If you have a large volume sitting at C2C or ALJ, let us know so you can be connected with someone at C2C, and they will let you submit a spreadsheet instead of completing forms for each individual case. If they cannot reopen the claim, you will not lose you place in line at the ALJ. 

Also, if you are submitting a claim for the first time reconsideration and you would like a formal telephone discussion, write this on the reconsideration form. C2C will take this into consideration.

An important note, C2C uses the contact information submitted with the appeal letter. Make sure all of your staff is aware of this information. This is a good opportunity for suppliers, especially those who have many claims pending at reconsiderations and at the ALJ. If you miss the deadline for the telephone discussion, you will be going through the standard reconsideration process. This is imperative to know because under the demonstration project, the C2C contractor is allowed to be more flexible with the coverage criteria and regulations. Outside of the demonstration project, going through the standard reconsideration process, the normal medical policies, rules, and regulations apply. 

Check out the C2C Innovation Solutions website for information. Let us know if you have any questions. 

Ronda Buhrmester, CRT, CFm                                                    
[email protected] 
217-493-5440


comments powered by Disqus

From Our Experts

OIG to Review PMD Repairs and PAP Supplies thumbnail OIG to Review PMD Repairs and PAP Supplies The Office of Inspector General (OIG) has updated its work plan to include new reviews for PAP replacement supplies and power mobility device repairs. In a recent article from HME News, Medicare paid approximately $945.8 million for replacement supplies in 2017 and 2018, but OIG has previously found that most claims did not comply with Medicare requirements and that DME suppliers often did not have the documentation required to support the need for replacement supplies. Are Inhalation Drugs the Next OIG Six Year Lookback Audit? thumbnail Are Inhalation Drugs the Next OIG Six Year Lookback Audit? Since 2010, the CMS's Comprehensive Error Rate Testing (CERT) program has identified nebulizers and related drugs (i.e., inhalation drugs) among the top 20 supplies with the highest improper Medicare payments. Based on prior reviews, the Office of Inspector General (OIG) conducted a nationwide review to determine if the suppliers included in the review complied with Medicare requirements when billing for inhalation drugs. Ronda Says: Are You Ready for Oct. 21? Group II Support Surfaces Enter Prior Authorization Program for All States thumbnail Ronda Says: Are You Ready for Oct. 21? Group II Support Surfaces Enter Prior Authorization Program for All States CMS announced in Dec. 30, 2015 a finalized rule creating a program called Condition of Payment Prior Authorization Program for Certain DMEPOS items. The Value and Importance of Bid Calculators for Round 2021 Competitive Bidding thumbnail The Value and Importance of Bid Calculators for Round 2021 Competitive Bidding If someone would have told me a year ago that for the next round of Competitive Bidding (CB) a Durable Medical Equipment (DME) supplier could lose $100,000, $250,000, $500,000, or even $1,000,000 or more in revenue by bidding rates that were equal to the rates that are in place today, I would have said you were crazy. How Competitive Bidding Will Impact Reimbursement Rates for Non-Bid Areas thumbnail How Competitive Bidding Will Impact Reimbursement Rates for Non-Bid Areas So, you think that because you do not serve or operate within a competitive bid area (CBA), that Round 2021 of the Competitive Bidding (CB) program for DMEPOS products and services doesn't matter to you or doesn't impact you and your business? Think again! Zip Code Designation Changes – Affecting Reimbursement Rates thumbnail Zip Code Designation Changes – Affecting Reimbursement Rates   Between the first and second quarter of 2019, a to... Round 2021 Details Just Announced - Timeline Included thumbnail Round 2021 Details Just Announced - Timeline Included This morning, CMS released the Request for Bid (RFB) details for the Round 2021 Competitive Bidding Progra... Round 2021 Competitive Bidding Details Announced thumbnail Round 2021 Competitive Bidding Details Announced From the desk of Mark Higley As VGM members are likely most aware from recent webinars and legislative u...